These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18598857)

  • 21. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    van den Broek PJ; Bohte R
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2200; author reply 2201-2. PubMed ID: 9550805
    [No Abstract]   [Full Text] [Related]  

  • 22. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Halpern MT; Cifaldi MA
    Clin Infect Dis; 2004 Jul; 39(1):144-5; author reply 145-6. PubMed ID: 15206068
    [No Abstract]   [Full Text] [Related]  

  • 24. [Initial empirical antibiotic treatment of community-acquired pneumonia in immunocompetent adult patients].
    ; ; ;
    Rev Esp Quimioter; 2003 Dec; 16(4):457-66. PubMed ID: 14961143
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving inpatient management of community-acquired pneumonia in remote northern Australia.
    Rémond M; Watts J; Maguire G
    Aust J Rural Health; 2008 Dec; 16(6):383-4. PubMed ID: 19032212
    [No Abstract]   [Full Text] [Related]  

  • 26. [The usefulness of the new prognostic classifications in the treatment of community acquired pneumonia].
    Gudiol F
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():77-8. PubMed ID: 9717166
    [No Abstract]   [Full Text] [Related]  

  • 27. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    Kullberg BJ; van Herwaarden CL; van der Meer JW
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2199-200; author reply 2201-2. PubMed ID: 9550804
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    Boersma WG; De Graaff CS
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2198-9; author reply 2201-2. PubMed ID: 9550803
    [No Abstract]   [Full Text] [Related]  

  • 29. Scenario 1: a patient with mild community-acquired pneumonia--introduction to clinical trial design issues.
    Gilbert DN
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S121-2. PubMed ID: 18986276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-acquired pneumonia guidelines: Peering back through the looking glass...clearly?
    Peterson MW; Hornick DB
    Am J Med; 2004 Nov; 117(10):799-800. PubMed ID: 15541330
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia also applicable in The Netherlands].
    Koolbergen K
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2201; author reply 2201-2. PubMed ID: 9644005
    [No Abstract]   [Full Text] [Related]  

  • 32. Doxycycline and community-acquired pneumonia.
    Woolley RJ
    Am Fam Physician; 1998 Feb; 57(3):426-7. PubMed ID: 9475892
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic therapy of childhood pneumonia.
    Schaad UB
    Pediatr Pulmonol Suppl; 1999; 18():146-9. PubMed ID: 10093127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Just the berries. Management of community-acquired pneumonia. Evidence-based update.
    Balter M
    Can Fam Physician; 2002 Nov; 48():1773-5. PubMed ID: 12489243
    [No Abstract]   [Full Text] [Related]  

  • 35. [Can macrolide treatment delay the diagnosis of tuberculosis?].
    Gómez Cubillos C; Carrión Valero F; Pascual Izuel JM
    An Med Interna; 1999 Jul; 16(7):385-6. PubMed ID: 10481348
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of community-acquired pneumonia.
    Johnson M
    Iowa Med; 1993 Sep; 83(9):339-42. PubMed ID: 8300373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia.
    Waterer GW; Grayson ML
    Intern Med J; 2007 Dec; 37(12):789-91. PubMed ID: 18028080
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs of choice for community-acquired bacterial pneumonia.
    Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
    [No Abstract]   [Full Text] [Related]  

  • 39. Identifying failure of empirical treatment for pneumonia: vigilance and common sense.
    Lim WS
    Thorax; 2004 Nov; 59(11):918-9. PubMed ID: 15516461
    [No Abstract]   [Full Text] [Related]  

  • 40. Should fluoroquinolones be first-line antibiotics in the treatment of community-acquired pneumonia in areas with high incidence of tuberculosis?
    Hsueh PR
    J Microbiol Immunol Infect; 2007 Oct; 40(5):386-7. PubMed ID: 17932596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.